Jincheng Pharmaceuticals: Two subsidiaries have received drug registration certificates for two products.

On February 25th, Jincheng Pharmaceuticals announced that its wholly-owned subsidiaries, Beijing Jincheng Tail Pharmaceutical Co., Ltd. and Shanghai Jincheng Suezhi Pharmaceutical Co., Ltd. respectively received the "Drug Registration Certificate" for metoprolol amlodipine tablets and cefdinir granules for suspension issued by the National Medical Products Administration. Metoprolol amlodipine tablets are a compound preparation composed of metoprolol and amlodipine, used as an alternative therapy for hypertension treatment in patients who are already taking the same dose of single drugs and have good blood pressure control. Cefdinir granules for suspension are oral anti-infective drugs used to treat mild to moderate infections in children caused by specified sensitive strains of microorganisms.